What if medicine could fix disease at its source… by rewriting the genetic code itself?In this episode of Petri Dish Perspectives, we dive into the incredible story of gene therapy, one of the most ambitious and transform...

Welcome to your essential overview of the global biotech and pharmaceutical landscape for January 2026!This month was dominated by a surge in Eli Lilly's deals, partnerships, etc. 🎧 Listen now, stay curious, and don’t forg...

What does it take to spend decades chasing one of medicine’s hardest problems while the rest of the industry walks away?In this episode, we explore the remarkable story of Eisai, the Japanese pharmaceutical company that built its ...

Flagship Pioneering doesn’t wait for scientific breakthroughs. It builds them. In this episode, we dive deep into the origin story of one of the most influential venture creation firms in biotech and the mind behind it, Noubar Afeyan. From his ...

Biogen is one of the most influential and controversial companies in modern biotechnology. Founded in the late 1970s by Nobel-level scientists who believed recombinant DNA would redefine medicine, Biogen helped turn neurology into a commercial ...